ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Summary - Guideline Central
Treatment
Document Overview

Treatment of Locally Advanced Esophageal Carcinoma

American Society of Clinical Oncology


Publication Date: Jul 28, 2021

Page Last Updated: May 5, 2026


Grading Table


Document Overview

Document Title
Treatment of Locally Advanced Esophageal Carcinoma
Authoring Society

American Society of Clinical Oncology

Document Publication Date
Jul 28, 2021
Page Last Reviewed/Updated
May 5, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
ascopubs.org/doi/full/10.1200/JCO.21.01831
Source Citation

Manish A. Shah, MD; Erin B. Kennedy, MHSc; Dan Catenacci, MD; et al. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. J Clin Oncol. 2021 July 28 doi: 10.1200/JCO.21.01831

Manish A. Shah, MD; Erin B. Kennedy, MHSc; Dan Catenacci, MD; Dana C. Deighton; Karyn A. Goodman, MD; Narinder K. Malhotra, MD; Christopher Willett, MD; Brendon Stiles, MD; Prateek Sharma, MD; Laura Tang, MD PhD; Bas P.L. Wijnhoven, MD, PhD; Wayne Hofstetter, MD. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. J Clin Oncol. 2020 June 22 doi: 10.1200/JCO.20.00866


Document Scope, Criteria, and Use Cases

Document Objectives

To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer.

Scope
Management, Treatment
Keywords
esophageal adenocarcinoma, esophageal carcinoma, squamous cell carcinoma
Inclusion Criteria
Male, Female, Adolescent, Adult, Older Adult
Health Care Settings
Hospital, Outpatient, Radiology Services
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resource
Data Supplement
Number of Source Documents
64
Literature Search Start Date
Friday, January 1, 1999
Literature Search End Date
Tuesday, December 31, 2019
Includes peer/external review process?
Yes
Includes public comment process?
Yes
Methodologist involvement?
Yes
Patient involvement?
Yes
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
Yes
Grades quality of strength of recommendation?
Yes
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
Yes
Identifies study selection process?
Yes
Identifies study selection criteria?
Yes
Identifies methods used to evaluate and analyze the evidence?
Yes
Identifies key questions addressed by the systematic review?
Yes
Identifies search strategy?
Yes
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.